title: Cutaneous phaeohyphomycosis.
abstract: BACKGROUND
  Phaeohyphomycosis is an infrequent infection in human beings. However, in recent years, its prevalence has augmented in immunosuppressed patients (mostly in solid organ transplanted patients). Infection can be mucocutaneous or disseminated. In the former, the fungus inoculation occurs mainly through traumatism. Lesions may be polymorphic and asymptomatic, isolated or multiple, and are usually localized in exposed areas of the limbs and head. Treatment is not standardized. When possible, surgical resection of the lesion is combined with systemic antifungals.
  
  
  METHODS
  We communicate three phaeohyphomycosis cases with cutaneous compromise.
  
  
  RESULTS
  The cases we present show diverse clinical characteristics and varied severity and evolution.
  
  
  CONCLUSIONS
  It is important for dermatologists to recognize this cutaneous fungus infection because the diagnosis using microscopic examination and mycological culture depends on the clinical suspicion.
authors.affiliation: Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Mariana P
authors.initials: MP
authors.lastname: Caviedes
authors.affiliation: Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Ana C
authors.initials: AC
authors.lastname: Torre
authors.affiliation: Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Maite Lisa
authors.initials: ML
authors.lastname: Eliceche
authors.affiliation: Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Denise C
authors.initials: DC
authors.lastname: Valdivia Monteros
authors.affiliation: Department of Pathology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Victoria I
authors.initials: VI
authors.lastname: Volonteri
authors.affiliation: Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.|Universidad de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Ricardo L
authors.initials: RL
authors.lastname: Galimberti
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003881:Dermatomycoses / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy*; D019115:Fasciitis, Necrotizing / Q000382:microbiology*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D008171:Lung Diseases / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D060446:Phaeohyphomycosis / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000628:therapy*
chemical_list: D000935:Antifungal Agents; C068538:liposomal amphotericin B; D017964:Itraconazole; D000666:Amphotericin B